Metabolite name | Trainings set | Test set | ||||
---|---|---|---|---|---|---|
Fold change | p Value | FDR | Fold change | p Value | FDR | |
CA19-9 | 18.36 | 6.89E-09 | 7.65E-06 | 14.27 | 3.17E-09 | 1.07E-06 |
Proline | 0.69 | 2.24E-05 | 0.0027 | 0.75 | 0.0001 | 0.0082 |
Sphingomyelin (d18:2,C17:0) | 1.15 | 0.005612 | 0.0400 | 1.15 | 0.0119 | 0.0696 |
Phosphatidylcholine (C18:0,C22:6) | 1.26 | 8.59E-05 | 0.0034 | 1.06 | 0.2091 | 0.4619 |
Isocitrate | 1.26 | 0.008074 | 0.0518 | 0.99 | 0.9159 | 0.9377 |
Sphinganine-1-phosphate (d18:0) | 0.79 | 0.025867 | 0.1175 | 0.85 | 0.0705 | 0.2430 |
Histidine | 0.77 | 0.000324 | 0.0073 | 0.79 | 0.0004 | 0.0109 |
Pyruvate | 0.93 | 0.367408 | 0.6114 | 0.97 | 0.6479 | 0.7976 |
Ceramide (d18:1,C24:0) | 0.79 | 0.001509 | 0.0167 | 0.80 | 0.0087 | 0.0583 |
Sphingomyelin (d17:1,C18:0) | 1.36 | 4.86E-05 | 0.0029 | 1.37 | 4.61E-05 | 0.0078 |
Univariate statistical analysis was done by a linear model on log10-transformed data with disease, gender, body mass index, age and storage time as fixed effects. Multiple testing was addressed by calculating the false discovery rate (FDR) described by Benjamini and Hochberg.